Balyasny Asset Management LLC Acadia Pharmaceuticals Inc Call Options Transaction History

Balyasny Asset Management LLC

  • $54.9 Billion
  • Q2 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$14.62 - $18.42 $2.92 Million - $3.68 Million
200,000 New
200,000 $3.25 Million
Q4 2023

Feb 14, 2024
BUY
$20.78 - $31.77 $2.08 Million - $3.18 Million
100,000 New
100,000 $3.13 Million
Q4 2020

Feb 16, 2021
SELL
$41.04 - $56.79 $6.16 Million - $8.52 Million
-150,000 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$36.42 - $57.0 $3.46 Million - $5.42 Million
95,000 Added 172.73%
150,000 $6.19 Million
Q3 2018

Nov 14, 2018
BUY
$13.03 - $21.81 $716,650 - $1.2 Million
55,000 New
55,000 $831,000

Others Institutions Holding ACAD

# of Institutions
288
Shares Held
161M
Call Options Held
723K
Put Options Held
257K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email